Current Edition

The Danish Approaches for Personalised Medicine – For the Benefit of Patients
Volume 13 Issue 1

The Danish Approaches for Personalised Medicine – For the Benefit of Patients

The term tailor-made or personalised medicine covers a form of drug treatment in which the use of drugs is adapted to the individual patient's special disease situat...
Continue Reading →
Key Considerations when Repositioning a Known Drug for Inhalation Therapy
Volume 13 Issue 1

Key Considerations when Repositioning a Known Drug for Inhalation Therapy

In recent years, the pharma industry has seen significant growth in finding new uses for old drugs. The repurposing and repositioning of existing drugs have become a...
Continue Reading →
A Greener Future for the Inhalation Industry: A Critical Year for our Climate
Volume 13 Issue 1

A Greener Future for the Inhalation Industry: A Critical Year for our Climate

This article explores the legislative and economic drivers of why the industry needs to adapt, and crucially why now is the time to act. It is also important to grou...
Continue Reading →
Connectivity, Cybersecurity and Medical Devices: What are the Threats?
Volume 13 Issue 1

Connectivity, Cybersecurity and Medical Devices: What are the Threats?

Developers of medical devices are taking inspiration from consumer products use of connected technology; realising that smarter devices offer huge benefits to patien...
Continue Reading →
Digital Medication Adherence in Clinical Trials
Volume 13 Issue 1

Digital Medication Adherence in Clinical Trials

Drug developers work tirelessly, progressing their compounds from the laboratory to the clinical phases, and rigorously assessing the medication use in Phase II and ...
Continue Reading →
Pharmacokinetic and Statistical Considerations in Firstin-human Clinical Trials – Case Study Article
Volume 13 Issue 1

Pharmacokinetic and Statistical Considerations in Firstin-human Clinical Trials – Case Study Article

The purpose of first-in-human (FIH) studies is to evaluate the pharmacology, tolerability, and safety of the drug or investigational medicinal product in humans for ...
Continue Reading →
How Approaches to Clinical Research are Set to Change in the ‘New Normal’
Volume 13 Issue 1

How Approaches to Clinical Research are Set to Change in the ‘New Normal’

2020 was an extraordinary year for the whole of humanity. But for the clinical research sector, it has proved to be particularly defining. Rising financial and time ...
Continue Reading →
Beta Glucans and Endotoxin Testing
Volume 13 Issue 1

Beta Glucans and Endotoxin Testing

The presence of bacterial endotoxins in different media, solutions and laboratory materials can be determined by utilising the limulus amebocyte lysate test. Lisa Ko...
Continue Reading →
Whitepaper: Together Beyond COVID-19 – A Look at the Future
Volume 13 Issue 1

Whitepaper: Together Beyond COVID-19 – A Look at the Future

To understand the challenges that the pharmaceutical industry faces during COVID-19, open-ended interviews were conducted with top pharmaceutical companies around Eu...
Continue Reading →
Redefining Healthcare: Digital Trends in 2021
Volume 13 Issue 1

Redefining Healthcare: Digital Trends in 2021

2020 has redefined healthcare for good. As with many industries, the impact of COVID-19 cannot be understated, as healthcare was placed at the centre of the global a...
Continue Reading →